Miller J M, Cossú S F, Chmielewski I L, Hsia H H, Rothman S A, Vogel R L, Buxton A E
Cardiac Electrophysiology Laboratory, Temple University Hospital, Philadelphia, Pennsylvania, USA.
Cardiol Clin. 1996 Nov;14(4):569-90. doi: 10.1016/s0733-8651(05)70305-2.
Direct treatment of atrial flutter and atrial fibrillation--that is, attempting to prevent arrhythmia recurrences by ablating atrial tissue--has been a challenge because of uncertainty about the location of optimal target tissues as well as the amount of atrial tissue requiring destruction to effect cure. Advances have yielded success rates for ablation of the common form of atrial flutter comparable to those for other types of supraventricular tachycardia and provide reason for optimism about the use of catheter techniques, to treat atrial fibrillation definitively. This article discusses some of these advances as well as the current status of catheter ablation for atrial flutter and atrial fibrillation and, finally, what the future may bring.
心房扑动和心房颤动的直接治疗——即试图通过消融心房组织来预防心律失常复发——一直是一项挑战,这是因为最佳目标组织的位置以及实现治愈所需破坏的心房组织量存在不确定性。取得的进展使常见类型心房扑动的消融成功率与其他类型室上性心动过速的成功率相当,并为使用导管技术彻底治疗心房颤动带来了乐观的理由。本文讨论了其中的一些进展以及心房扑动和心房颤动导管消融的现状,最后探讨了未来可能的发展。